Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Shared on07 May 25
Fair value Increased 0.73%

Shared on30 Apr 25
Fair value Increased 0.098%

Shared on23 Apr 25
Fair value Increased 8.61%

AnalystHighTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 8.02%

AnalystHighTarget has increased revenue growth from 5.6% to 8.5%.

Biosimilars And Targeted Therapies Will Expand Global Chronic Care Markets

Shared on07 May 25Fair value Increased 0.73%

Shared on30 Apr 25Fair value Increased 0.098%

Shared on23 Apr 25Fair value Increased 8.61%

Shared on16 Apr 25Fair value Decreased 8.02%

Shared on07 May 25
Fair value Increased 0.73%

Shared on30 Apr 25
Fair value Increased 0.098%

Shared on23 Apr 25
Fair value Increased 8.61%

Shared on16 Apr 25
Fair value Decreased 8.02%